FPGEE practice question 3 of 10

Which of the following is not directly related to a drug toxicity of Ibuprofen?

Full set: 426 questions
Answer options
A: Nausea
B: Renal dysfunction
C: Anemia
D: Muscle wasting Correct answer
Correct Answer:
D. Muscle wasting
Explanation

Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) that non-selectively inhibits cyclooxygenase enzymes (COX-1 and COX-2), reducing prostaglandin synthesis. Direct and indirect toxicity manifestations include gastrointestinal adverse events such as nausea, dyspepsia, mucosal erosion, and ulceration. Chronic GI mucosal injury or covert microvascular bleeding can produce iron-deficiency anemia, while acute severe bleeding causes acute normocytic anemia. Furthermore, inhibition of renal vasodilatory prostaglandins (PGE2 and PGI2) leads to decreased renal blood flow, reduced glomerular filtration rate, sodium retention, and acute renal dysfunction or papillary necrosis. Muscle wasting, however, is a classic manifestation of chronic glucocorticoid excess or steroid myopathy and is not a direct adverse toxic effect of nonsteroidal anti-inflammatory therapy.

Why Incorrect

A. Nausea is a common direct gastrointestinal adverse effect resulting from COX-1 inhibition and reduced protective gastric mucosal prostaglandin synthesis.
B. Renal dysfunction occurs due to renal prostaglandin inhibition, disrupting autoregulation of renal blood flow and glomerular filtration pressure.
C. Anemia develops secondary to NSAID-induced gastrointestinal ulceration, overt microvascular blood loss, or rare drug-induced bone marrow suppression.

References

1. Brunton, L. L., Hilal-Dandan, R., & Knollmann, B. C. (Eds.). (2018). Goodman & Gilman's: The Pharmacological Basis of Therapeutics (13th ed., pp. 685–692). McGraw-Hill Education.

2. US Food and Drug Administration (FDA). Ibuprofen Tablet Prescribing Information (Label Reference ID: 3912048).

3. Wongrakpanich, S., et al. (2018). A Comprehensive Review of Non-Steroidal Anti-Inflammatory Drug Use in The Elderly. Aging and Disease, 9(1), 143–150. https://doi.org/10.14336/AD.2017.0303

Scroll to Top